InflaRx N.V. (IFRX) vs Vogenx (VOGX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Vogenx is the larger company by market cap ($259.8 million vs $225.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IFRX | VOGX |
|---|---|---|
| Share price | $1.53 | $17.49 |
| Market cap | $225.47M | $259.82M |
| 1-day change | -1.92% | +8.23% |
| YTD return | +51.49% | — |
| 1-year return | +4.08% | — |
| 5-year return | -38.06% | — |
| EPS (TTM) | $-0.58 | $-0.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.95 | $38.41 |
| 52-week low | $0.798 | $12.95 |
| Distance from 52-week high | -48.12% | -54.46% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +400.65% | +214.47% |
| Average volume | 798.72K | 187.66K |
| Shares outstanding | 147.37M | 14.86M |
| Employees | 65 | 4 |
| Sector | Healthcare | Health Care |
| Industry | Biotechnology | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: InflaRx N.V. in Healthcare and Vogenx in Health Care.
About InflaRx N.V.
IFRX stock →InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator to treat variety of autoimmune and other inflammatory diseases.
Healthcare · Biotechnology · 65 employees
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
IFRX vs VOGX FAQ
Which is bigger, InflaRx N.V. or Vogenx?
Vogenx (VOGX) is larger, with a market capitalization of $259.82M compared with $225.47M for InflaRx N.V. (IFRX).
Are InflaRx N.V. and Vogenx in the same industry?
No. InflaRx N.V. is in the Healthcare sector, while Vogenx is in Health Care.